Library
Safety guides, dosing protocols, reconstitution math, and plain-English references for every peptide in the category.
Dosing protocols
BPC-157 Dosage Protocol
In short: BPC-157 has 200+ animal studies, zero completed human efficacy trials, and a research-chem-only supply chain ā the gap between hyp
CJC-1295 (No-DAC) Dosage Protocol
CJC-1295 without the drug-affinity complex (commonly labeled "CJC-1295 no-DAC" or by its original research designation "Modified GRF 1-29")
GHK-Cu Dosage Protocol
In short: GHK-Cu has the strongest topical-dermatology evidence of any peptide on TriedRx and the thinnest injectable human data ā the case
Ipamorelin Dosage Protocol
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) developed in the late 1990s as a selective growth hormone secretagogu
Retatrutide Dosage Protocol
The phase 2 retatrutide obesity trial (n = 338) reported a mean body weight reduction of 24.2% at 48 weeks on the 12 mg weekly dose, the lar
Semaglutide Dosage Protocol
The STEP 1 trial randomized 1,961 adults with obesity to semaglutide 2.4 mg weekly or placebo and reported a mean body weight reduction of 1
TB-500 Dosage Protocol
In short: TB-500 is a short fragment of thymosin beta-4 dosed in the low-milligram range weekly, supported by preclinical TĪ²4 data ā but the
Tirzepatide Dosage Protocol
SURMOUNT-1 randomized 2,539 adults with obesity to tirzepatide 5, 10, or 15 mg weekly or placebo for 72 weeks, and the 15 mg arm reported a